re: Far East Pharma - HK listed - earnings - stock split
stock shot up to pre split $3.84
Since I own a nice position in Far East Pharmaceutical, listed on the HK exchange I would like to point to their excelent earnings statement which came out Monday..
To support this, the company also conducted a 1:4 forward stock split. The shares shot up to post split HK$0.96 (pre split HK$3.84) an all time high..
Old ticker - 0399.HK - New ticker 2973.HK - 1 old share equals 4 new shares. It's a tad complicated how a split works in HK it seems.. Company also announced to repurchase up to 10% of their issued shares on the open market..
Detailed report in .pdf format can be obtained directly
from the HK Exchange retrieval system which works similar
to SEC's EDGAR : hkex.com.hk
FE PHARMA TECH<00399> - Results Announcement (Summary)
Far East Pharmaceutical Technology Co., Limited announced on 27/10/2003: (stock code: 00399 )
Year end date: 30/06/2003
Currency: HKD
Auditors' Report: Unqualified
(Audited )
(Audited ) Last
Current Corresponding
Period Period
from 01/07/2002 from 01/07/2001
to 30/06/2003 to 30/06/2002
Note ('000 ) ('000 )
Turnover : 992,961 715,717
Profit/(Loss) from Operations : 238,145 175,608
Finance cost : (2,636) (520)
Share of Profit/(Loss) of
Associates : N/A N/A
Share of Profit/(Loss) of
Jointly Controlled Entities : N/A (131)
Profit/(Loss) after Tax & MI : 175,040 134,739
% Change over Last Period : +29.91 %
EPS/(LPS)-Basic (in dollars) : 0.344 per 0.335 per
share of HK$0.1 share of HK$0.1
-Diluted (in dollars) : 0.334 per 0.314 per
share of HK$0.1 share of HK$0.1
Extraordinary (ETD) Gain/(Loss) : N/A N/A
Profit/(Loss) after ETD Items : 175,040 134,739
Final Dividend : 8 cents per share 4.5 cents per
per Share of HK$0.10 share of HK$0.10
(i.e. 2 cents per
subdivided share
of HK$0.025)
(Specify if with other : N/A N/A
options)
B/C Dates for
Final Dividend : 12/12/2003 to 18/12/2003bdi.
Payable Date : 31/12/2003
B/C Dates for Annual
General Meeting : 12/12/2003 to 18/12/2003bdi.
Other Distribution for : N/A
Current Period
B/C Dates for Other
Distribution : N/A
Remark:
EARNINGS PER SHARE
The calculation of the basic and diluted earnings per share for
the year is based on the following data:
2003 2002
HK$'000 HK$'000
Earnings:
Profit attributable to shareholders and earnings for
the purposes of basic earnings per share
175,040 134,739
Effect of dilutive potential shares:
Redeemable convertible bonds - interest expenses
- 520
---------- ----------
Profit attributable to shareholders and earnings
for the purposes of diluted earnings per share
175,040 135,259
==========================
2003 2002
Number of shares:
Weighted average number of shares for the purposes
of basic earnings per share 508,932,602 402,331,726
Effect of dilutive potential shares:
Share options 15,648,762 16,192,057
Redeemable convertible bonds - 12,035,976
------------ ------------
Weighted average number of shares for the purposes
of diluted earnings per share 524,581,364 430,559,759
============ ============
The computation of diluted earnings per share for the year ended 30 June
2003 does not assume the conversion of the Company's outstanding warrants
since its exercise would result in an increase in earnings per share for
the year. |
